LOGIN  |  REGISTER
Compass Therapeutics

Enhabit Home Health & Hospice Announces Date of 2022 Fourth Quarter Earnings Call

January 24, 2023 | Last Trade: US$7.80 0.09 1.17

DALLAS / Jan 24, 2023 / Business Wire / Enhabit, Inc. (NYSE: EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2022, on Feb. 14, 2023, and host a webcast and conference call on Feb. 15, 2023. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time.

  • Feb. 15, 2023
  • 10:00 a.m. Eastern
  • Toll-free: 888-660-6150
  • International: 929-203-0843
  • Conference ID: 5248158
  • Internet website: https://investors.ehab.com

A link to the webcast of the conference call and online replay can be found on Enhabit’s investor website at the web address provided above.

About Enhabit Home Health & Hospice

Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit’s team of clinicians supports patients and their families where they are most comfortable, with a nationwide footprint spanning 252 home health locations and 105 hospice locations across 34 states. Enhabit leverages advanced technology and compassionate teams to deliver extraordinary patient care. For more information, visit ehab.com.

Assertio

Stock Quote

Featured Stock

Terns Pharmaceuticals

Terns Pharmaceuticals is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule product candidates to address serious diseases, including oncology and obesity. Terns’ pipeline contains three clinical stage development programs including GLP-1 receptor...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page